#Glioblastome: #PAC1 améliore le traitement chez la #souris et maintenant chez le #chien. Essai clinique en cours chez l'#humain https://t.co/3V9ER9iJjq #Pretzel https://t.co/IHLE0r9oLq
Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients https://t.co/xloHbGl0iQ
Joshi, et al. featured on the cover of #Oncotarget https://t.co/fPOqQobSqk discuss here https://t.co/wUocIxqDHW #Science #Research #Oncology https://t.co/g7lWn3MRmR
RT @NeuroGen_papers: PubMed: Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma… ht…
synergistic& targeted therapy with a procaspase-3 activator& temozolomide feasible for malignant #glioma in dogs https://t.co/FqwugT1Ii8 https://t.co/FnepbInlWj
Synergistic and targeted therapy with a procaspase-3 activator and temozolomide in rodent models for canine gliomas https://t.co/xloHbG3pri
PubMed: Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma… https://t.co/kmJRfp8Mx7